KRICT has developed TS-20003

Summary

KRICT (Korea Research Institute of Chemical Technology has developed TS-20003, which has displayed testing results in stopping liver fibrosis by controlling the process of ‘autophagy’. The institute has transferred this technology to Thoth Science Inc.

Link to Full Articles (in Korean)

먹는 간경변 치료제 신약 후보물질 개발 (2019-07-03)

화학硏, 간경변 전단계 간섬유화 막는 신약 후보물질 개발 (2019-07-02)

NewsMarton Praczki